Published in West J Med on January 01, 2000
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health (2005) 1.18
Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep (2002) 1.13
Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nurs Res (2008) 1.11
Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial. J Infect Dis (2010) 0.97
Feasibility of completing an accelerated vaccine series for homeless adults. J Viral Hepat (2009) 0.86
Correlates of hepatitis B virus and HIV knowledge among gay and bisexual homeless young adults in Hollywood. Am J Mens Health (2012) 0.85
Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study. Addict Sci Clin Pract (2013) 0.84
Vaccination could improve overall health in a high risk population. West J Med (2000) 0.83
Hepatitis B vaccination among research participants, Seattle, Washington. Am J Public Health (2002) 0.83
Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users. Am J Public Health (2015) 0.79
Past exposure to hepatitis B: a risk factor for increase in mortality? J Clin Gastroenterol (2014) 0.77
Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia. J Urban Health (2012) 0.76
A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania. PLoS One (2016) 0.75
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health (1996) 5.45
The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69
Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep (1991) 3.46
Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis (1991) 3.29
From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis (1990) 2.38
Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med (1992) 2.01
Prevalence of sexual risk behaviour and substance use among runaway and homeless adolescents in San Francisco, Denver and New York City. Int J STD AIDS (1997) 1.94
Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health (1990) 1.80
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol (1995) 1.65
High compliance with a hepatitis B virus vaccination program among intravenous drug users. J Infect Dis (1991) 1.60
A risk profile of street youth in northern California: implications for gender-specific human immunodeficiency virus prevention. J Adolesc Health (1997) 1.59
Hepatitis B vaccine series compliance in adolescents. Pediatr Infect Dis J (1994) 1.45
Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis (1989) 1.45
Utilization of medical services by drug abusers in detoxification. J Subst Abuse (1993) 1.20
Routine hepatitis B vaccination in a clinic for sexually transmitted diseases. Am J Public Health (1995) 1.16
Update: recommendations to prevent hepatitis B virus transmission--United States. MMWR Morb Mortal Wkly Rep (1995) 1.10
Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine (1989) 1.10
Status report on the Childhood Immunization Initiative: national, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1996. MMWR Morb Mortal Wkly Rep (1997) 1.04
Compliance of hepatitis B vaccination in patients presenting to a teenage clinic. Pediatr Infect Dis J (1994) 0.95
Compliance with immunization against hepatitis B. A pragmatic study in sexually transmitted disease clinics. Vaccine (1995) 0.89
Inadequate hepatitis B vaccination of adolescents and adults at an urban community health center. J Natl Med Assoc (1997) 0.88
Universal hepatitis B immunization: the British Columbia experience. Vaccine (1995) 0.87
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health (1994) 5.18
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health (1987) 5.06
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med (1993) 5.00
The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med (1995) 4.60
Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis (1998) 3.89
HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA (1994) 3.80
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health (2001) 3.43
A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med (1999) 3.26
High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis (2000) 2.71
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Protease inhibitors in the homeless. JAMA (1997) 2.57
Use of T lymphocyte subset analysis in the case definition for AIDS. J Acquir Immune Defic Syndr (1993) 2.57
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology (2001) 2.54
Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med (1998) 2.52
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Incubation period of AIDS in San Francisco. Nature (1989) 2.26
The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (2000) 2.20
AIDS and intravenous drug use: the real heterosexual epidemic. Br Med J (Clin Res Ed) (1987) 2.08
Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health (2001) 2.02
Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97
Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med (1998) 1.96
Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction (1999) 1.94
Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med (1996) 1.92
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr (2000) 1.87
Overdosing among young injection drug users in San Francisco. Addict Behav (2001) 1.84
Sex trading and psychological distress among women recruited from the streets of Harlem. Am J Public Health (1997) 1.81
Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med (2000) 1.71
Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence. Clin Immunol Immunopathol (1986) 1.68
Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis (1990) 1.67
Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.65
Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst (1984) 1.59
Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol (1994) 1.58
Tuberculosis in Mexican-born persons in San Francisco: reactivation, acquired infection and transmission. Int J Tuberc Lung Dis (1997) 1.57
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis (1996) 1.56
Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol (1997) 1.52
Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet (1993) 1.50
Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med (2000) 1.44
Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.44
The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. The Multicenter Crack Cocaine and HIV Infection Study Team. Sex Transm Dis (1998) 1.42
Invited commentary: needle exchange--no help for hepatitis? Am J Epidemiol (1999) 1.35
Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol (1994) 1.34
Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32
Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis (1988) 1.31
Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis (2004) 1.31
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend (1996) 1.31
Tracking and follow-up of marginalized populations: a review. J Health Care Poor Underserved (1999) 1.29
Detention of persistently nonadherent patients with tuberculosis. JAMA (1997) 1.28
Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest (1989) 1.25
Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis (1993) 1.22
Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr (2001) 1.22
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.21
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat (2008) 1.21
Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals. Qual Life Res (2003) 1.20
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology (1996) 1.19
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology (1996) 1.17
Locating study subjects: predictors and successful search strategies with inmates released from a U.S. county jail. Control Clin Trials (2001) 1.17
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med (1998) 1.17
Antibody to the retrovirus associated with the acquired immunodeficiency syndrome (AIDS). Presence in presumably healthy San Franciscans who died unexpectedly. Arch Intern Med (1986) 1.15
Crack cocaine use and sexual activity in Miami, Florida. J Psychoactive Drugs (1993) 1.12
Propionate precursors and other metabolic intermediates as possible alternative electron acceptors to methanogenesis in ruminal fermentation in vitro. Br J Nutr (2005) 1.10
Quality control of birth defect registry data: a case study. Public Health Rep (1993) 1.10
Immune activation markers and AIDS prognosis. AIDS (1991) 1.09
Epidemiology of AIDS in developed countries. Br Med Bull (1988) 1.07
Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction. AIDS (1991) 1.06
A case-control study of pancreatic carcinoma. J Cancer Res Clin Oncol (1982) 1.06
Self-disclosure of HIV-1 antibody test results: the San Francisco General Hospital Cohort. AIDS Educ Prev (1995) 1.04
Sex trading and psychological distress in a street-based sample of low-income urban men. J Psychoactive Drugs (2001) 1.03
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther (2008) 1.02
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database Syst Rev (2006) 1.00
A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis (1998) 0.99
Differences in laboratory values in HIV infection by sex, race, and risk group. AIDS (1992) 0.98
Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco. Clin Immunol Immunopathol (1989) 0.98
Ultrastructure of sickling and unsickling in time-lapse studies. Br J Haematol (1976) 0.97
Association between time homeless and perceived health status among the homeless in San Francisco. J Community Health (1997) 0.96
Cancer screening in homeless women: attitudes and behaviors. J Health Care Poor Underserved (1998) 0.96
Street talk: knowledge and attitudes about tuberculosis and tuberculosis control among homeless adults. Int J Tuberc Lung Dis (1999) 0.96
Effect of new AIDS case definition on numbers of cases among homosexual and bisexual men in San Francisco. JAMA (1991) 0.96
Pulmonary changes following hemorrhagic shock and resuscitation in baboons. J Thorac Cardiovasc Surg (1970) 0.96
Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults. Cochrane Database Syst Rev (2005) 0.95
Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. Int J Tuberc Lung Dis (2003) 0.95
Use of health care services by women who use crack cocaine. Women Health (1999) 0.95